UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis

Frontiers in oncology, 2020-02, Vol.10, p.91-91

2020

Volltextzugriff (PDF)

Incidence of Diabetic Ketoacidosis Among Pediatrics With Type 1 Diabetes Prior to and During COVID-19 Pandemic: A Meta-Analysis of Observational Studies

Frontiers in endocrinology (Lausanne), 2022-03, Vol.13, p.856958-856958

2022

Volltextzugriff (PDF)

The landscape of biosimilars in Saudi Arabia: preparing for the next decade

Expert opinion on biological therapy, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-10

2023

Volltextzugriff (PDF)

Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan

Journal of medical economics, 2023-12, Vol.26 (1), p.835-842

2023

Volltextzugriff (PDF)

Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals

Saudi pharmaceutical journal, 2023-04, Vol.31 (4), p.510-516

2023

Volltextzugriff (PDF)

Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis

Cardiovascular diabetology, 2020-06, Vol.19 (1), p.1-96, Article 96

2020

Volltextzugriff (PDF)

1003-P: Incidence of Severe Diabetic Ketoacidosis among Children with Type 1 Diabetes Mellitus Prior to and During COVID-Pandemic: A Meta-analysis

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective

Saudi pharmaceutical journal, 2022-04, Vol.30 (4), p.433-439

2022

Volltextzugriff (PDF)

Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER–Medicare database

Therapeutic advances in drug safety, 2021, Vol.12, p.2042098621991279-2042098621991279

2021

Volltextzugriff (PDF)

17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials

Frontiers in medicine, 2021-12, Vol.8, p.764855-764855

2021

Volltextzugriff (PDF)

The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines

Thrombosis journal, 2021-10, Vol.19 (1), p.1-76, Article 76

2021

Volltextzugriff (PDF)

445-P: Network Meta-analysis of Seven Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Outcome Trials Data

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis

BMJ open, 2020-09, Vol.10 (9), p.e036138-e036138

2020

Volltextzugriff (PDF)

Comparative Risk of Acute Kidney Injury Following Concurrent Administration of Vancomycin with Piperacillin/Tazobactam or Meropenem: A Systematic Review and Meta-Analysis of Observational Studies

Antibiotics (Basel), 2022-04, Vol.11 (4), p.526

2022

Volltextzugriff (PDF)

Effectiveness and Safety of Non–vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses

Clinical therapeutics, 2017-07, Vol.39 (7), p.1456-1478.e36

2017

Volltextzugriff (PDF)

Comparative effectiveness of glucagon‐like peptide‐1 receptor agonists for the management of obesity in adults without diabetes: A network meta‐analysis of randomized clinical trials

Obesity reviews, 2023-03, Vol.24 (3), p.e13543-n/a

2023

Volltextzugriff (PDF)

Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis

Critical reviews in oncology/hematology, 2019-10, Vol.142, p.16-25

2019

Volltextzugriff (PDF)

Retrospective evaluation of safety and effectiveness of same-day pegfilgrastim in patients with lung cancer

Future oncology (London, England), 2022-06, Vol.18 (19), p.2381-2390

2022

Volltextzugriff (PDF)

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma

JAMA dermatology (Chicago, Ill.), 2019-01, Vol.155 (1), p.22

2019

Volltextzugriff (PDF)

Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective

The Annals of pharmacotherapy, 2023-09, Vol.57 (9), p.1016

2023

Volltextzugriff (PDF)

Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study

Value in health, 2024-05, Vol.27 (5), p.552-561

2024

Volltextzugriff (PDF)

Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data

Expert opinion on drug safety, 2021-04, Vol.20 (4), p.489-497

2021

Volltextzugriff (PDF)

A comparison of the pharmacologic and nonpharmacologic strategies used to manage chronic pain: Opioid users versus nonusers

Journal of the American Pharmacists Association, 2019-09, Vol.59 (5), p.691-697

2019

Volltextzugriff (PDF)

Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis

Expert opinion on drug safety, 2020-03, Vol.19 (3), p.327-334

2020

Volltextzugriff (PDF)

Update on Cardiovascular Safety of Incretin-Based Therapy in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials

Canadian journal of diabetes, 2019-10, Vol.43 (7), p.538-545.e2

2019

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(29)
Dissertationen
(1)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Potential Immune-Related Adverse Events Associated With Monotherapy and Combination Therapy of Ipilimumab, Nivolumab, and Pembrolizumab for Advanced Melanoma: A Systematic Review and Meta-Analysis

Incidence of Diabetic Ketoacidosis Among Pediatrics With Type 1 Diabetes Prior to and During COVID-19 Pandemic: A Meta-Analysis of Observational Studies

The landscape of biosimilars in Saudi Arabia: preparing for the next decade

Cost-efficiency analysis and expanded treatment access modeling of conversion to rituximab biosimilars from reference rituximab in Jordan

Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals

Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis

1003-P: Incidence of Severe Diabetic Ketoacidosis among Children with Type 1 Diabetes Mellitus Prior to and During COVID-Pandemic: A Meta-analysis

Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective

Association of immune-checkpoint inhibitors and the risk of immune-related colitis among elderly patients with advanced melanoma: real-world evidence from the SEER–Medicare database

17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials

The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines

445-P: Network Meta-analysis of Seven Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Outcome Trials Data

Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis

Comparative Risk of Acute Kidney Injury Following Concurrent Administration of Vancomycin with Piperacillin/Tazobactam or Meropenem: A Systematic Review and Meta-Analysis of Observational Studies

Effectiveness and Safety of Non–vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses

Comparative effectiveness of glucagon‐like peptide‐1 receptor agonists for the management of obesity in adults without diabetes: A network meta‐analysis of randomized clinical trials

Comparative efficacy and safety of immunotherapies targeting the PD-1/PD-L1 pathway for previously treated advanced non-small cell lung cancer: A Bayesian network meta-analysis

Retrospective evaluation of safety and effectiveness of same-day pegfilgrastim in patients with lung cancer

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma

Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective

Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study

Immune checkpoint inhibitors-associated risk of immune-related hypothyroidism in older patients with advanced melanoma: a real-world analysis of US SEER-Medicare data

A comparison of the pharmacologic and nonpharmacologic strategies used to manage chronic pain: Opioid users versus nonusers

Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis

Update on Cardiovascular Safety of Incretin-Based Therapy in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis of Cardiovascular Outcome Trials

Suchergebnisse filtern